Top Markets
#1 DogBull DogBull +54.48%
#2 Siren Siren +30.82%
#3 OriginTrail OriginTrail +17.82%
#4 Yield Basis Yield Basis +14.21%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.05%
#6 Cysic Cysic +9.48%
#7 COTI COTI +8.70%
#8 Purr Purr +8.26%
#9 Stargate Finance Stargate Finance +7.94%
#10 MetYa MetYa +7.11%
Coin of the day
DogBull DogBull
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Pozycja w akcjach #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Cena akcji
$0.3479
Ostatnia synchronizacja: 2024-08-21
Kapitalizacja rynkowa
$94.92M
Zmiana (1 dzień)
0.64%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Asensus Surgical, Inc. (ASXC)

Kategoria

Healthcare
Marża operacyjna dla Asensus Surgical, Inc. (ASXC)
Marża operacyjna na dzień August 2026 TTM: -926.52%
Według najnowszych raportów finansowych i ceny akcji Asensus Surgical, Inc., bieżąca marża operacyjna (TTM) wynosi -926.52%. Na koniec 2022 wynosiła -1,067.86%.
Historia marży operacyjnej dla Asensus Surgical, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) -926.52% 0.00%
2023 -926.52% -13.24%
2022 -1,067.86% 36.04%
2021 -784.97% -58.73%
2020 -1,902.02% 4.97%
2019 -1,811.92% 788.50%
2018 -203.93% -76.58%
2017 -870.86% -89.30%
2016 -8,140.16% 0.00%
2015 0.00% -100.00%
2014 -9,129.43% 410.24%
2013 -1,789.24% 468.63%
2012 -314.66% 0.00%
2011 0.00% -100.00%
2010 18,431.03% 0.00%
2009 0.00% 0.00%
2008 0.00% -100.00%
2007 2,052.59% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% -100.00%
2003 -462.77% 1,370.04%
2002 -31.48% 842.51%
2001 -3.34% -265.35%
2000 2.02% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.02%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.02%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.02%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.02%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.